Access to safe, quality specialty medications without exorbitant costs
NASH helps employers, third-party administrators (TPAs) and stop-loss carriers save money on specialty medications. We offer over 450 brand-name drugs sourced directly from manufacturers or licensed wholesalers, ensuring authenticity through a secure supply chain.
As part of our patient-centered model, we partner with licensed pharmacies in Tier 1 healthcare countries to deliver uninterrupted therapies via personal importation or direct shipment to our U.S.-based customers.
Seamless Access. Smarter Drug Savings. TM
EMPLOYER BENEFITS
NASH delivers an average of 40 to 60% savings on specialty medications.
Attract and retain top workers with an elevated benefits package that includes a NASH specialty pharmacy benefit. It’s easy to add NASH services at any time during the plan year: simply amend the Summary Plan Description (SPD) and begin onboarding with NASH.
And, your dedicated NASH account manager will provide customized implementation assistance with ERISA-compliant materials, marketing and communications assistance, and reports to show your accumulated savings.
EMPLOYER SOLUTIONS
No barriers to access with flexible, convenient specialty pharmacy program options.
Our assessment-based option is when a patient’s medical records are reviewed for appropriateness of medication therapy, and then a prescription is written aligned with domestic therapy. All medications are shipped directly to the patient.
Our travel-for-treatment option is when a patient travels to licensed pharmacy partner location for each medication dispense as needed.
Our telehealth option is used to facilitate a patient-physician relationship when needed to meet compliance requirements.
We are grateful for your partnership!
NASH consistently goes above and beyond to ensure our members receive tailored support. Their team is always responsive and attentive, promptly addressing questions to ensure smooth, worry-free experiences.
EMPLOYER RESOURCES
Find helpful employer resources
ARTICLE
Tackling specialty drug affordability
CONTACT US
Book a free consultation
FEEDBACK